Fig. 1From: Hydroxyurea Optimization through Precision Study (HOPS): study protocol for a randomized, multicenter trial in children with sickle cell anemiaHOPS schedule of evaluations. All study-related procedures are outlined in this figure. The primary endpoint will be assessed at month 6 and the study will continue for a total of 12 months of hydroxyurea therapyBack to article page